Reports indicate an increase in VIP release during myocardial infarction, potentially acting as a protective mechanism (Gyongyosi et al., 1997), and it is released into the coronary circulation in both normal and diseased hearts (Kupari et al., 2006), suggesting VIP may have a critical role in modulating cardiac function. This evidence concerns the gene VIP and myocardial infarction.